Torrent Pharmaceuticals Limited (TORNTPHARM) - Total Assets

Latest as of September 2025: Rs155.15 Billion INR ≈ $1.68 Billion USD

Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) holds total assets worth Rs155.15 Billion INR (≈ $1.68 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Torrent Pharmaceuticals Limited's book value for net asset value and shareholders' equity analysis.

Torrent Pharmaceuticals Limited - Total Assets Trend (2005–2025)

This chart illustrates how Torrent Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data.

Torrent Pharmaceuticals Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Torrent Pharmaceuticals Limited's total assets of Rs155.15 Billion consist of 37.5% current assets and 62.5% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs2.32 Billion	3.9%
Accounts Receivable	Rs18.67 Billion	12.5%
Inventory	Rs25.41 Billion	17.0%
Property, Plant & Equipment	Rs38.23 Billion	25.5%
Intangible Assets	Rs42.63 Billion	28.4%
Goodwill	Rs3.39 Billion	2.3%

Asset Composition Trend (2005–2025)

This chart illustrates how Torrent Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Torrent Pharmaceuticals Limited stock valuation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Torrent Pharmaceuticals Limited's current assets represent 37.5% of total assets in 2025, an increase from 37.3% in 2005.
Cash Position: Cash and equivalents constituted 3.9% of total assets in 2025, up from 1.5% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 13.0% in 2005.
Asset Diversification: The largest asset category is intangible assets at 28.4% of total assets.

Torrent Pharmaceuticals Limited Competitors by Total Assets

Key competitors of Torrent Pharmaceuticals Limited based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Regencell Bioscience Holdings Ltd NASDAQ:RGC	USA	$5.76 Million
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥31.46 Billion
Yuhan Corp. KO:000100	Korea	₩3.05 Trillion
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	China	CN¥8.15 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Guobang Pharma Ltd SHG:605507	China	CN¥10.58 Billion

Torrent Pharmaceuticals Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.39	1.21	1.17
Quick Ratio	0.84	0.74	0.65
Cash Ratio	0.16	0.24	0.00
Working Capital	Rs17.36 Billion	Rs10.32 Billion	Rs8.41 Billion

Torrent Pharmaceuticals Limited - Advanced Valuation Insights

This section examines the relationship between Torrent Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	15.78
Latest Market Cap to Assets Ratio	0.10
Asset Growth Rate (YoY)	-0.5%
Total Assets	Rs149.90 Billion
Market Capitalization	$15.32 Billion USD

Valuation Analysis

Below Book Valuation: The market values Torrent Pharmaceuticals Limited's assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Torrent Pharmaceuticals Limited's assets decreased by 0.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Torrent Pharmaceuticals Limited (2005–2025)

The table below shows the annual total assets of Torrent Pharmaceuticals Limited from 2005 to 2025.

Year	Total Assets	Change
2025-03-31	Rs149.90 Billion ≈ $1.62 Billion	-0.47%
2024-03-31	Rs150.61 Billion ≈ $1.63 Billion	+0.32%
2023-03-31	Rs150.12 Billion ≈ $1.62 Billion	+14.60%
2022-03-31	Rs131.00 Billion ≈ $1.42 Billion	-6.93%
2021-03-31	Rs140.75 Billion ≈ $1.52 Billion	+0.26%
2020-03-31	Rs140.38 Billion ≈ $1.52 Billion	-0.59%
2019-03-31	Rs141.21 Billion ≈ $1.53 Billion	-0.86%
2018-03-31	Rs142.43 Billion ≈ $1.54 Billion	+40.67%
2017-03-31	Rs101.25 Billion ≈ $1.09 Billion	+12.33%
2016-03-31	Rs90.14 Billion ≈ $974.79 Million	+13.94%
2015-03-31	Rs79.11 Billion ≈ $855.55 Million	+56.04%
2014-03-31	Rs50.70 Billion ≈ $548.28 Million	+34.02%
2013-03-31	Rs37.83 Billion ≈ $409.10 Million	+23.08%
2012-03-31	Rs30.74 Billion ≈ $332.39 Million	+20.61%
2011-03-31	Rs25.48 Billion ≈ $275.60 Million	+29.68%
2010-03-31	Rs19.65 Billion ≈ $212.52 Million	+17.85%
2009-03-31	Rs16.67 Billion ≈ $180.33 Million	+31.73%
2008-03-31	Rs12.66 Billion ≈ $136.90 Million	+21.14%
2007-03-31	Rs10.45 Billion ≈ $113.01 Million	+10.94%
2006-03-31	Rs9.42 Billion ≈ $101.86 Million	+32.54%
2005-03-31	Rs7.11 Billion ≈ $76.85 Million	--

About Torrent Pharmaceuticals Limited

NSE:TORNTPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$15.32 Billion

Rs1.42 Trillion INR

Market Cap Rank

#1583 Global

#49 in India

Share Price

Rs4185.10

Change (1 day)

-1.10%

52-Week Range

Rs3127.80 - Rs4446.00

All Time High

Rs4446.00